Page 36 - Sohini Das

Hyundai, vendors set to line up Rs 10,000 crore for Talegaon plant

Tata Motors and Ford India signed deal for the latter's Sanand unit for Rs 725 cr in 2022

Fewer generics enter market after linagliptin's patent expiry this August

When Sitagliptin went off patent, nearly 200 brands were vying for a share of the market

Number of women in blue-collar jobs increasing across manufacturing sector

As companies move to be more gender inclusive

Tata Motors to acquire 26.79% stake in Freight Tiger for Rs 150 crore

Tata Motors has already introduced its connected vehicle platform 'Fleet Edge' for aiding fleet operations management

Biocon Biologics appoints Kedar Upadhye as new chief financial officer

Current CFO, MB Chinappa will take on a strategic finance role at Biocon Group

Stand 'firmly' with General Motors Talegaon workers: Maharashtra CM

State government assures workers, says better compensation, jobs among solutions being worked out

Bajaj Auto Ltd Q2FY24 results: PAT up 17.5%, riding on better product mix

After Diwali, Bajaj Auto plans to introduce six new products and upgrades in the 125 cc plus category

PLI scheme effect? Bulk drug imports from China slow, shows data

Experts say scheme to boost local manufacturing will take 5-7 years to show tangible results

CEAT eyes market leadership in EV tyres within the next two years

Banerjee said that Ceat is focusing on specialty tyres, whether for agricultural use or other segments

War cry for 50%: Maruti's rise to number 1 in SUVs is the result of rejig

Hatchbacks still constitute 30 per cent of the passenger vehicle market. The top three cars in India are still small cars: Swift, Baleno and WagonR. Incidentally, all three are Maruti models

Ceat Q2 PAT jumped 32-fold, helped by better product mix, price hikes

The company declared results post market hours. The company's stock was down marginally (1.7 per cent) on the BSE to Rs 2,101 apiece

Tata Motors rides Jaguar Land Rover on road to turn net cash positive

On track to pare debt, analysts expect it to have Rs 2K cr cash on the books by end-FY25

Auto industry Q2 preview: Product mix, commodity tailwinds to aid margins

Brokerages expect marginal drop in two-wheeler volumes

Rolling in luxury: Top-end carmakers spin wheels of bespoke experience

From drifting and slaloming on sheets of ice to bending laws of motorsport physics, auto majors curate thrills beyond the road

Phase-IV data shows Cequa helped improve dry eye disease: Sun Pharma

Cequa or cyclosporine ophthalmic solution is indicated to increase tear production in patients with dry eye

Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life

Some 40-50 firms in India are getting into mRNA technology, says Aditya Sharma, senior executive of the German company

Pharma result preview: US stable, India muted in the second quarter

Hospital occupancy rates rise 200-400 bps, while diagnostic sector sees seasonal benefits

Anant Goenka named VC for RPG, retains role in CEAT, Zensar Technologies

Educated at the Wharton School and holding an MBA from the Kellogg School of Management, Goenka initiated his professional journey with Unilever and RPG's KEC International

Russia's loss can be India's gain in clinical trial shift, say experts

India's contribution to global clinical trials has been around 4 percent in the last decade while it's the second most populous country in the world, and has one-fifth of the global disease burden

Serum Institute of India, Mylab launch TB kit for latent infections

The partnership between SII and Mylab is focusing on creating a comprehensive ecosystem for TB diagnosis, treatment, and prevention through various interventions